Abstract: The present invention relates to a method of diagnosing bladder cancer in an individual. Further, the present invention relates to a method of determining the course of bladder cancer in an individual. Furthermore, the present invention relates to a kit for diagnosing bladder cancer in an individual or determining the course of bladder cancer in an individual.

Abstract: The present invention relates to a eukaryotic initiation factor (eIF) modulating compound for use in the treatment of a tumor and in the diagnosis of a cancer. The present invention also relates to a method of diagnosing lung cancer in an individual and to a method of providing a prognosis to an individual suffering from lung cancer. Furthermore, the present invention relates to a method of diagnosing colorectal cancer in an individual, a method of differentiating between colon cancer (CC) and rectum cancer (RC) in an individual, a method of determining whether an individual responds to a therapeutic treatment of colorectal cancer, and to a method of determining the course of colorectal cancer in an individual.

Abstract: The present invention relates to a method of diagnosing Head and Neck Squamous Cell Carcinoma (HNSCC) in an individual. In addition, the present invention relates to a method of providing a survival prognosis to an individual suffering from Head and Neck Squamous Cell Carcinoma (HNSCC). Moreover, the present invention relates to a kit for performing the above-mentioned methods.

Abstract: The present invention relates to a eukaryotic initiation factor (eIF) modulating compound for use in the treatment of a tumor and in the diagnosis of a cancer. The present invention also relates to a method of diagnosing lung cancer in an individual and to a method of providing a prognosis to an individual suffering from lung cancer. Furthermore, the present invention relates to a method of diagnosing colorectal cancer in an individual, a method of differentiating between colon cancer (CC) and rectum cancer (RC) in an individual, a method of determining whether an individual responds to a therapeutic treatment of colorectal cancer, and to a method of determining the course of colorectal cancer in an individual.

Abstract: The present invention relates to a method of diagnosing bladder cancer in an individual. Further, the present invention relates to a method of determining the course of bladder cancer in an individual. Furthermore, the present invention relates to a kit for diagnosing bladder cancer in an individual or determining the course of bladder cancer in an individual.

Abstract: The present invention relates to a method of diagnosing Head and Neck Squamous Cell Carcinoma (HNSCC) in an individual. In addition, the present invention relates to a method of providing a survival prognosis to an individual suffering from Head and Neck Squamous Cell Carcinoma (HNSCC). Moreover, the present invention relates to a kit for performing the above-mentioned methods.

Abstract: The present invention is in the field of tumor prognosis and relates to a method of providing a prognosis to an individual suffering from a tumor. Further, the present invention relates to a method of diagnosing a hepatocellular carcinoma (HCC) in an individual, a method of diagnosing a hepatitis C virus (HCV) infectionin an individual, a method of diagnosing a hepatitis B virus (HBV) infection in an individual, and a method of diagnosing a viral induced hepatocellular carcinoma in an individual. Furthermore, the present invention relates to a method of differentiating between at least two conditions in an individual, wherein the at least two conditions are selected from the group consisting of a hepatocellular carcinoma (HCC), hepatitis C virus (HCV) infection, hepatitis B virus (HBV) infection, and a viral induced hepatocellular carcinoma (HCC). In addition, the present invention relates to a method for diagnosing a lymphoma in an individual.